Filing Details

Accession Number:
0001104659-22-032997
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-11 17:45:44
Reporting Period:
2022-03-09
Accepted Time:
2022-03-11 17:45:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124524 Cryoport Inc. CYRX Pharmaceutical Preparations (2834) 880313393
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1848218 W Mark Sawicki C/O Cryoport Inc.
112 Westwood Place, Suite 350
Brentwood TN 37027
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-09 2,667 $0.00 52,796 No 4 M Direct
Common Stock Disposition 2022-03-09 1,410 $31.05 51,386 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Rights Disposition 2022-03-09 2,667 $0.00 2,667 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,000 No 4 M Direct
Footnotes
  1. Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
  2. Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
  3. The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022.